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ABSTRACT 
 
 
 
 
Metallocene polyethylene (mPE) has been known for its excellent physical 
and mechanical properties, but its poor hemocompatibility limits its clinical 
application. Objective of this study was to analyze the physicochemical properties 
and blood compatibility of mPE following nitric acid (HNO3) treatment. 
Characterization tests were performed using 3D Hirox, SEM, AFM, contact angle 
and FTIR. Blood compatibility of the sample was studied by conducting blood 
coagulation assays; hemolysis assay, PT, APTT, platelet adhesion and protein 
adsorption test. Result shows that the contact angle of the mPE treated with HNO3 
decreased from 86º to 69.7º. Surface of the mPE and the HNO3 treated mPE 
investigated with FTIR revealed no major changes in its functional groups. 3D Hirox 
digital microscopy, SEM and AFM images show increased porosity and surface 
roughness. The protein adsorption studies show that the adsorbed albumin increased 
and adsorbed fibrinogen decreased in 60 minutes HNO3 treated sample. Blood 
coagulation assays prothrombin time (PT) and activated partial thromboplastin time 
(APTT) were delayed significantly (P < 0.05) for the 60 minutes HNO3 treated 
sample. Hemolysis assay and platelet adhesion of the treated surface resulted in 
reduced lysis of red blood cells and platelet adherence indicating improved 
hemocompatibility of HNO3 treated mPE. To determine that HNO3 does not 
deteriorate elastic modulus of mPE, the elastic modulus, tensile strength and tensile 
strength at break of mPE and HNO3 treated mPE was compared and the result shows 
that HNO3 treatment does not deteriorate the mechanical properties of mPE. To 
conclude, the overall observation suggests that the novel HNO3 treated mPE may 
hold great potential to be exploited for various temporary blood contacting devices 
like catheters, endoscopy tip and etc. 
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ABSTRAK 
 
 
 
 
 Metallocene polietilena (mPE) lebih dikenali dengan sifat-sifat fizikal dan 
mekanikal yang mengagumkan, namun masalah keserasian dengan darah 
menghadkan aplikasi klinikal bahan ini. Objektif kajian ini adalah untuk 
menganalisis sifat-sifat fizikokimia dan keserasian darah mPE selepas rawatan asid 
nitrik (HNO3). Ujian pencirian telah dilakukan dengan menggunakan 3D Hirox, 
SEM, AFM , sudut kenalan dan FTIR. Keserasian darah sampel telah dikaji dengan 
cerakin pembekuan darah seperti cerakin hemolisis, PT, APTT, bilangan platelet 
melekat dan ujian penyerapan protein. Sudut sentuhan bagi mPE yang 
ditindakbalaskan dengan HNO3 telah menurun daripada 86º kepada 69.7º. Analisis 
FTIR menunjukkan tiada sebarang perbezaan yang ketara dari segi kumpulan 
berfungsi antara mPE dan mPE yang ditidakbalaskan dengan HNO3. Imej pada 
mikroskop digital 3D Hirox, SEM dan AFM telah menunjukkan peningkatan dari 
segi saiz liang dan kekasaran permukaan. Kajian penyerapan protein menunjukkan 
bahawa serapan albumin meningkat manakala penyerapan fibrinogen menurun bagi 
mPE yang ditindakbalaskan dengan  HNO3 selama 60 minit. Masa bagi cerakin 
pembekuan darah bagi prothrombin (PT) dan separa tromboplastin yang diaktifkan 
(APTT) mempunyai perbezaan yang ketara (P < 0.05) untuk mPE yang 
ditindakbalaskan dengan HNO3. Cerakin hemolisis dan lekatan platelet untuk 
permukaan yang ditindakbalas mengurangkan lisis sel-sel darah merah dan 
pematuhan platelet menunjukkan sifat keserasian dengan darah yang baik untuk mPE 
yang ditindakbalaskan dengan HNO3. Tiada perubahan dari segi sifat-sifat mekanik; 
elastik modulus dan kekuatan tegangan tercatat antara sampel mPE sebelum atau 
selepas ditidakbalaskan dengan HNO3. Oleh itu, analisis keseluruhan menunjukkan 
bahawa mPE yang ditindakbalaskan dengan HNO3 mempunyai kebarangkalian yang 
positif untuk diaplikasikan sebagai peranti sementara yang bersentuhan dengan darah 
seperti kateter, tip endoskopi dan lain-lain lagi. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background 
 
 
Materials which have been playing a vital role in replacing and mirroring the 
functions of various organs in human system [1] are collectively known as 
biomaterials. Biomaterial is the combination of substances originating from natural, 
inorganic or organic materials. These materials are biocompatible exactly or partially 
when it comes in contact with the body during the healing time. They involve 
complete or part of a living organism or biomedical device which perform, augments 
or replaces any natural functions. Biomaterials are commonly used in various 
medical devices and systems like synthetic skin [2], drug delivery systems [3], tissue 
cultures [4], hybrid organs [5], synthetic blood vessels [6], artificial heart valves, 
cardiac pacemakers [7], screws, plates, wires and pins for bone treatments, total 
artificial joint implants, skull reconstruction [8], dental and maxillofacial applications 
[9].  
 
 
Biomaterials broadly fall into the four main types namely metals, ceramics, 
polymers and biological substances [10]. Metals have unique atomic structure which 
confers them characteristic strength and properties which enable them specifically 
for load-bearing applications like orthopaedics. However, the corrosion associated 
with the use of metals limits their utility. Ceramics have evolved as better 
biomaterials because of their bio-inertness and compatibility. However, due to 
brittleness and low impact strength [11], ceramics are losing popularity. Polymers 
2 
 
have widespread applications in the field of biomaterials. Properties of polymers are 
dependent on the unit macromolecule present in the long chain of the polymer. 
 
 
Among all four types, the polymers have widespread application in the field 
of biomaterials because of excellent physico-chemical and mechanical properties. 
Moreover, polymers can be feasibly molded into desired shapes with desired 
mechanical characteristics. The most important application of polymers is 
cardiovascular based implants [7] and blood contacting devices [1]. The use of 
polymers in medical application ranges from vascular grafts, stents, prosthetic heart 
valves, catheters, heart assist devices, hemodialyser.  
 
 
Modern revolution in polymer technology like metallocene single-site 
catalyst introduced a new class of polyolefins with improved performance properties 
like enhanced toughness, sealability, clarity, and elasticity [12]. The metallocene 
consists of two cyclopentadienyl anions (Cp,) which are bound to a metal center (M) 
[12] which has an oxidation state II, thereby resulting in a general formula M(C5H5)2. 
One among the polymers developed through metallocene technology is metallocene 
polyethylene (mPE). mPE typically finds applications in disposable bags, storage 
bottles, blood bags, and syringe tubes. Even though mPE has outstanding 
permeability to oxygen and acts as a barrier towards ammonia and water, mPE lacks 
blood compatibility [13] to be used for blood contacting biomedical implants. 
 
 
Biocompatibility is a prime factor which determines the quality of a 
biomaterial and its application in various arenas. There are different definitions for 
biocompatibility. It may be defined as the ability of the material to perform at a 
specific body site with an appropriate host reaction. Biocompatibility may also be 
defined as the ability of a biomaterial to perform its desired function with respect to a 
medical therapy, without eliciting any undesirable local or systemic effects in the 
recipient or beneficiary of that therapy, but generating the most appropriate 
beneficial cellular or tissue response to that specific situation and optimizing the 
clinically relevant performance of that therapy [14].  
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Biocompatibility has been mentioned in many works with increasing interest 
in evaluating the characteristics of medical materials and devices and also the 
responses caused by its components. The ideal pattern for determining these 
properties has not yet been determined; but, various methods have been suggested for 
this purpose. Biocompatibility encompasses many aspects of the material, including 
its physical, mechanical and chemical properties, and potential cytotoxic, mutagenic 
and allergenic effects [15], so that no significant injuries or toxic effects on the 
biological function of cells and individuals arise. Until the biocompatibility of a 
material is proven, it must be subjected to various studies ranging from in vitro 
assays to clinical trials, involving distinct areas such as pharmaceutics, biology, 
chemistry and toxicology to justify its use as a biomaterial. 
 
 
The term biocompatibility has been defined by consensus, but not blood 
compatibility. The interactions between blood and a surface depend on the blood 
composition, the blood flow and the surface of the material defined by its 
physicochemical feature. The design of bloodcompatible materials is clearly a 
challenge to increase success in all medical devices that come in contact with blood 
and to answer unsolved problems in vascular reconstruction.  
 
 
To explain blood compatibility from a different perspective, consider a 
material that is not blood compatible, i.e. a thrombogenic material. Such material 
would produce specific adverse reactions when placed in contact with blood: 
formation of clot or thrombus composed of various blood elements; shedding or 
nucleation of emboli (detached thrombus); the destruction of circulating blood 
components and activation of the complement system and other immunologic 
pathways [10]. Thus, we can define blood compatibility as the ability of the material 
to work in a particular place without eliciting any of the above mentioned blood 
related complications. Indeed, biocompatibility of blood contacting devices relates 
mainly to the thrombotic response induced by the materials. 
 
 
Several distinct but interrelated thrombotic and antithrombotic systems exist 
to prevent the formation of intravascular clots expected in response to vascular 
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trauma. Haemostasis is the sum of these mechanisms and serves to limit blood loss 
following injury. Once regulation is initiated, these same mechanisms combine first 
to localize the clot at the site of injury, then to terminate coagulation and finally to 
remove the clot once it has served its purpose. These haemostatic mechanisms 
include platelet activation, coagulation, fibrinolysis and local vascular effects. Blood 
clotting, platelet adhesion and giant cell formations are major problems associated 
with blood clotting devices. These problems frequently arise in cardiovascular 
implants since the material is always in contact with blood and its components [7].  
 
 
The hypothesis of this thesis was that the HNO3 treatment on mPE may 
improve the blood compatibility of the mPE polymer, to be utilized for different 
temporary blood contacting devices application like endscope tip, catheters and etc. 
The rationale for this hypothesis was that, when the mPE surface is subjected to 
HNO3 treatment it was expected to etch the mPE surface which may improve the 
wetabbility or hydrophilicity of mPE. It may be expected that improved 
hydrophilicity may alter the protein adsorption and blood coagulation time resulting 
in enhanced blood compatibility. Besides that, it is also hypothesized that the HNO3 
treatment on mPE will not affect the mechanical strength of mPE. 
 
 
 
 
1.2 Statement of Problem 
 
 
Although mPE has excellent physico-chemical and mechanical properties, it 
fails as a promising biomaterial because of its poor blood compatibility. 
Biocompatibility is a vital factor which determines the quality of a biomaterial and 
its application in various arenas. It may be defined as the ability of the material to 
perform at a specific region with the appropriate host reaction. The events occur 
when the blood comes in contact with the implant is collectively called as blood 
mediated reactions or blood compatibility. Whenever the blood comes in contact 
with the implants (biomaterial) it will lead to following complications:  
 
5 
 
1. Blood components interaction with surfaces resulting in protein and water 
adsorption. 
2. Blood cells interfere with the surface of biomaterial.  
3. These actions lead to the hemostasis and coagulation.  
 
 
 To solve these issues, different surface modification techniques have been 
studied yet most of them are complex and limited to certain family of polymers. In 
recent times, millions of dollars was invested in advanced biomaterial research which 
includes discovery of new alternatives. However, in order to cater the high demand, 
more research needs to be encouraged to enhance the properties of the existing 
medical materials using feasible, eco-friendly and affordable modification technique. 
Hence, nitric acid surface modification technique on mPE was performed for 
improving its blood compatibility and it is the research gaph which will be addressed 
in this research.  
 
 
 
 
1.3 Objectives 
 
 
This research was carried out to determine the potential of nitric acid (HNO3) 
treated metallocene polyethylene (mPE) as a biomaterial, for blood contacting device 
application. The following are the objectives of this study: 
1. To investigate the physico-chemical changes induced on the surface of the 
mPE after HNO3 treatment. 
 
2. To determine the changes in the blood compatibility of the mPE subjected to 
acid treatment. 
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1.4 Scope of Study  
 
 
This study consists of two parts. The first part of the study is focused mainly 
on the sample preparation, optimization of the nitric acid treatment on the mPE, and 
the characterization of mPE and HNO3 treated mPE surfaces. Various methods were 
utilized; contact angle, attenuated total reflectance Fourier Transform Infrared 
Spectroscopy (ATR-FTIR), 3D Hirox digital microscopy, scanning electron 
microscopy (SEM), and atomic force microscopy (AFM) for the determination of the 
surface characteristic of the mPE and HNO3 treated sample. To examine whether the 
HNO3 treatment affect the tensile strength, elastic modulus and break strength of 
mPE, mechanical testing of mPE and HNO3 treated mPE was compared.  
 
 
In the second part, blood coagulation assays were carried out. The reason for 
this step is to ascertain the thromboresistance property of mPE and HNO3 treated 
mPE surfaces when they are utilized as biomaterials, particularly for blood 
contacting devices. The blood coagulation assays like prothrombin test (PT), 
activated partial thromboplastin time (APTT), hemolysis assay (HA), and platelet 
adherence test is performed to investigate the blood compatibility of the mPE and 
HNO3 treated mPE. Protein adsorption assay was carried out for determining the 
specific proteins albumin and fibrinogen adsorption on mPE and HNO3 treated mPE. 
The mPE and the HNO3 treated mPE blood compatibility results were compared with 
the conventional blood contacting materials for positioning this research with related 
studies in this field.  
 
 
 
 
1.5 Significance of Study 
 
 
 The result of this study will provide an account on the improved blood 
compatibility of mPE by nitric acid treatment. In addition to that, the effect of the 
HNO3 on the mPE polymer which was performed for the first time may kindle the 
enthusiasm of the other researchers to further explore the alternative acids available, 
to enhance the blood compatibility of polymers. Besides that, as nitric acid is low in 
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cost, a cost effective method for the blood compatibility enhancement of polymers 
can be introduced.  
 
 
 
 
1.6 Thesis outline 
 
 
 This thesis is divided into five chapters. In Chapter 1, a brief explanation 
about the biomaterials and the research background of this study is given. Further, 
the objectives of this study have been presented in the context of solving the clinical 
complications mentioned. Finally, the importance of the proposed method and its 
influence in encouraging future researches is also projected. 
 
 
 In Chapter 2, a brief explanation about polymers and the problems observed 
during its contact with biological environment is summarized. In addition, the 
importance of surface modification techniques in solving those issues and some of 
the previous researches reported in that viewpoint is also discussed.  
 
 
In Chapter 3, the research methodology and characterization studies followed 
in this research are given in detail. The discussions mainly cover the particulars, 
procedures and the need for characterization studies.  
 
 
In Chapter 4, the results obtained from characterization and blood 
compatibility studies have been discussed and compared with the previous study’s 
results. This section is the heart of the thesis, since it evidently reflects the 
achievement and the effectiveness of proposed idea.  
 
 
In Chapter 5, a short summary of the whole work and its effectiveness in 
approaching blood compatibility problems are projected. Moreover, some suggestion 
about future research in the proposed perspective is also presented.  
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